Sufentanil
In the US, Sufentanil (sufentanil systemic) is a member of the drug class narcotic analgesics and is used to treat Anesthesia.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N01AH03
CAS registry number (Chemical Abstracts Service)
0056030-54-7
Chemical Formula
C22-H30-N2-O2-S
Molecular Weight
386
Therapeutic Categories
Opioid analgesic
Anesthetic, injectable
Chemical Name
Propanamide, N-[4-(metoxymetyl)-1-[2-(2-tienyl)etyl]-4-piperidinyl]-N-phenyl-
Foreign Names
- Sufentanilum (Latin)
- Sufentanil (German)
- Sufentanil (French)
- Sufentanilo (Spanish)
Generic Names
- Sufentanil (OS: BAN, USAN, DCF, DCIT)
- R 30730 (IS: Janssen)
- Sufentanil (PH: BP 2016, Ph. Eur. 8)
- Sufentanilum (PH: Ph. Eur. 8)
- Sufentanil Citrate (OS: BANM, USAN)
- R 33800 (IS)
- Sufentanil (citrate de) (PH: Ph. Eur. 8)
- Sufentanil Citrate (PH: BP 2016, Ph. Eur. 8, USP 38)
- Sufentanil citrate (PH: Ph. Eur. 8)
- Sufentanilcitrat (PH: Ph. Eur. 8)
- Sufentanili citras (PH: Ph. Eur. 8)
Brand Names
- Sufenta
Janssen-Cilag, Tunisia; Johnson & Johnson, Indonesia - Sufentamed
Unimed, Tunisia - Sufentanil Chiesi
Chiesi, Slovakia - Sufentanil Forte Labatec
Labatec Pharma, Switzerland - Sufentanil Hameln
Sanolabor, Slovenia - Sufentanil Labatec
Labatec Pharma, Switzerland - Sufentanil Renaudin
LENIS, Slovenia - Sufentanilo G.E.S
Ges Genericos, Spain - Zalviso
Grünenthal, France - Disufen
Angenerico, Italy - Fastfen
Cristalia, Brazil - Fentatienil
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F S., Italy - Pharma-Q Sufentanil
Pharma-Q, South Africa - Sufenta
Akorn, United States; GlaxoSmithKline, Netherlands; Janseen Pharmaceutica, Oman; Janssen, Brazil; Janssen, Chile; Janssen, Finland; Janssen, Iceland; Janssen, Norway; Janssen, South Africa; Janssen Cilag, Argentina; Janssen-Cilag, Belgium; Janssen-Cilag, Switzerland; Janssen-Cilag, Czech Republic; Janssen-Cilag, Germany; Janssen-Cilag, Denmark; Janssen-Cilag, France; Janssen-Cilag, Portugal; Janssen-Cilag Pharma, Austria; Johnson & Johnson, Slovakia - Sufenta Forte
Janseen Pharmaceutica, Oman; Janssen, Belgium; Janssen, Finland; Janssen Cilag, Serbia; Janssen-Cilag, Czech Republic - Sufenta forte
GlaxoSmithKline, Netherlands; Janssen Cilag, Netherlands; Janssen-Cilag, Switzerland - Sufenta mite
Janssen-Cilag, Germany - Sufenta-epidural
Janssen-Cilag, Germany - Sufentanil Actavis
Actavis Group, Austria - Sufentanil Chiesi
Chiesi Pharmaceuticals, Poland - Sufentanil Citrate Sandoz
Sandoz, Canada - Sufentanil Eurocept
Eurocept, France - Sufentanil Hameln
Hameln, Portugal; Hospira Italia, Italy; Matrix Pharmaceuticals, Denmark - Sufentanil HEXAL
Hexal, Germany - Sufentanil Mylan
Mylan, France; Mylan, Belgium - Sufentanil Narcomed
EuroCept, Netherlands - Sufentanil Renaudin
Renaudin, France - Sufentanil Torrex
Chiesi, Hungary; Torrex, Czech Republic; Torrex-Chiesi, Romania - Sufentanil-Actavis
Actavis, Germany - Sufentanil-hameln
Hameln Pharmaceuticals, Austria; Hameln, Netherlands; Hameln Pharma Plus, Germany - Sufentanilo Hikma
Hikma, Portugal - Zalviso
Grunenthal, United Kingdom - Zuftil
Pisa, Mexico
Glossary
Term | Definition |
---|---|
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.